SMARTAG Trademark

Trademark Overview

On Tuesday, June 18, 2013, a trademark application was filed for SMARTAG with the United States Patent and Trademark Office. The USPTO has given the SMARTAG trademark a serial number of 85963028. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Thursday, October 5, 2023. This trademark is owned by CATALENT PHARMA SOLUTIONS, INC.. The SMARTAG trademark is filed in the Chemical Products and Pharmaceutical Products categories with the following description:

Pharmaceutical preparations for the prevention or treatment of human diseases, namely, diseases of the immune system, respiratory system, cardiovascular system, digestive system, endocrine system, lymphatic system, muscular system, skeletal system, nervous system, urinary system, integumentary system and reproductive system; chemical, biological and biochemical preparations for medical and pharmaceutical purposes, namely, antibody-drug conjugates or any protein conjugated to a drug, poly nucleotide, another protein, chemical, or other functional entity or such preparations used as linker or payload molecules therein used to treat cancer and diseases and disorders of the immune system, respiratory system, cardiovascular system, digestive system, endocrine system, lymphatic system, muscular system, skeletal system, nervous system, urinary system, integumentary system and reproductive system; pharmaceutical preparations, namely, polypeptide bioconjugates and polynucleic acid bioconjugates...

Chemical, biochemical and biological reagents in the nature of or used to create or improve antibody-drug conjugates or any protein conjugated to a drug, poly nucleotide, another protein, chemical, or other functional entity used in industry and science; chemicals for use in bioconjugation, reversible bioconjugation, irreversible bioconjugation, reversible cysteine protection, surface modification, and prodrug production for scientific use; biochemicals, namely, polypeptides, polypeptides for in vivo applications, polypeptides for in vitro applications, polynucleic acids, polynucleic acids for in vivo applications, and polynucleic acids for in vitro applications for scientific use; biomolecules, namely, proteins, peptides, antibodies, antibody fragments, antibody mimetic proteins, and polynucleic acids for scientific use; chemical products for diagnostic use, namely, conjugates of polypeptides with small molecule drugs, imaging agents, flourocromes and radiolabels for medical research ...
smartag

General Information

Serial Number85963028
Word MarkSMARTAG
Filing DateTuesday, June 18, 2013
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateThursday, October 5, 2023
Registration Number5054933
Registration DateTuesday, October 4, 2016
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 2, 2014

Trademark Statements

Goods and ServicesPharmaceutical preparations for the prevention or treatment of human diseases, namely, diseases of the immune system, respiratory system, cardiovascular system, digestive system, endocrine system, lymphatic system, muscular system, skeletal system, nervous system, urinary system, integumentary system and reproductive system; chemical, biological and biochemical preparations for medical and pharmaceutical purposes, namely, antibody-drug conjugates or any protein conjugated to a drug, poly nucleotide, another protein, chemical, or other functional entity or such preparations used as linker or payload molecules therein used to treat cancer and diseases and disorders of the immune system, respiratory system, cardiovascular system, digestive system, endocrine system, lymphatic system, muscular system, skeletal system, nervous system, urinary system, integumentary system and reproductive system; pharmaceutical preparations, namely, polypeptide bioconjugates and polynucleic acid bioconjugates for use in diagnosis and treatment of cancer and diseases and disorders of the immune system, respiratory system, cardiovascular system, digestive system, endocrine system, lymphatic system, muscular system, skeletal system, nervous system, urinary system, integumentary system and reproductive system; biological preparations, namely, polypeptide bioconjugates and polynucleic acid bioconjugates for use in diagnosis and treatment of cancer and diseases and disorders of the immune system, respiratory system, cardiovascular system, digestive system, endocrine system, lymphatic system, muscular system, skeletal system, nervous system, urinary system, integumentary system and reproductive system; diagnostic preparations for medical purposes in connection with the diagnosis and treatment of cancer and diseases and disorders of the immune system, respiratory system, cardiovascular system, digestive system, endocrine system, lymphatic system, muscular system, skeletal system, nervous system, urinary system, integumentary system and reproductive system; antibody preparations, namely, antibody or protein bioconjugates for use in diagnosis and treatment of cancer and diseases and disorders of the immune system, respiratory system, cardiovascular system, digestive system, endocrine system, lymphatic system, muscular system, skeletal system, nervous system, urinary system, integumentary system and reproductive system, including antibody/protein-drug conjugates, antibody/protein-radiolabled conjugates and antibody/protein-imaging agent conjugates; chemical products for medical diagnostic use, namely, polypeptide bioconjugates and polynucleic acid bioconjugates for use in diagnosis and treatment of cancer and diseases and disorders of the immune system, respiratory system, cardiovascular system, digestive system, endocrine system, lymphatic system, muscular system, skeletal system, nervous system, urinary system, integumentary system and reproductive system; biochemical preparations, namely, polypeptide bioconjugates and polynucleic acid bioconjugates for use in diagnosis and treatment of cancer and diseases and disorders of the immune system, respiratory system, cardiovascular system, digestive system, endocrine system, lymphatic system, muscular system, skeletal system, nervous system, urinary system, integumentary system and reproductive system
Pseudo MarkSMAR TAG
Goods and ServicesChemical, biochemical and biological reagents in the nature of or used to create or improve antibody-drug conjugates or any protein conjugated to a drug, poly nucleotide, another protein, chemical, or other functional entity used in industry and science; chemicals for use in bioconjugation, reversible bioconjugation, irreversible bioconjugation, reversible cysteine protection, surface modification, and prodrug production for scientific use; biochemicals, namely, polypeptides, polypeptides for in vivo applications, polypeptides for in vitro applications, polynucleic acids, polynucleic acids for in vivo applications, and polynucleic acids for in vitro applications for scientific use; biomolecules, namely, proteins, peptides, antibodies, antibody fragments, antibody mimetic proteins, and polynucleic acids for scientific use; chemical products for diagnostic use, namely, conjugates of polypeptides with small molecule drugs, imaging agents, flourocromes and radiolabels for medical research applications; biochemical preparations, namely, polypeptides, polynucleic acids, and antibodies, all for use in basic scientific research and development, medical research; diagnostic preparations for scientific or research use in connection with antibody drug conjugates; biochemical preparations, namely, polypeptides, polynucleic acids, and antibodies, all for use in diagnosis and treatment of cancer and diseases and disorders of the immune system, respiratory system, cardiovascular system, digestive system, endocrine system, lymphatic system, muscular system, skeletal system, nervous system, urinary system, integumentary system and reproductive system

Classification Information

International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateThursday, June 27, 2013
Primary Code001
First Use Anywhere DateMonday, October 20, 2014
First Use In Commerce DateMonday, October 20, 2014
International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, June 27, 2013
Primary Code005
First Use Anywhere DateMonday, October 20, 2014
First Use In Commerce DateMonday, October 20, 2014

Trademark Owner History

Party NameCATALENT PHARMA SOLUTIONS, INC.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSomerset, NJ 08873
Party NameCATALENT PHARMA SOLUTIONS, INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSomerset, NJ 08873
Party NameCATALENT PHARMA SOLUTIONS, INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSomerset, NJ 08873

Trademark Events

Event DateEvent Description
Thursday, October 5, 2023NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Thursday, October 5, 2023REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Thursday, October 5, 2023CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, April 4, 2023TEAS SECTION 8 & 15 RECEIVED
Monday, October 4, 2021COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Wednesday, May 22, 2019ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Tuesday, October 4, 2016REGISTERED-PRINCIPAL REGISTER
Wednesday, August 31, 2016NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, August 30, 2016ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, August 9, 2016STATEMENT OF USE PROCESSING COMPLETE
Wednesday, July 13, 2016USE AMENDMENT FILED
Saturday, August 6, 2016CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, July 13, 2016TEAS STATEMENT OF USE RECEIVED
Tuesday, January 19, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, January 15, 2016SOU EXTENSION 1 GRANTED
Friday, January 15, 2016SOU EXTENSION 1 FILED
Friday, January 15, 2016SOU TEAS EXTENSION RECEIVED
Wednesday, September 2, 2015PETITION TO DIRECTOR GRANTED
Monday, August 31, 2015ASSIGNED TO PETITION STAFF
Tuesday, August 4, 2015TEAS PETITION TO DIRECTOR RECEIVED
Tuesday, July 28, 2015NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Saturday, July 25, 2015APPLICANT SUPPLIED CHANGES/CORRECTIONS AFTER PUB APPROVAL NOT ENT
Wednesday, July 22, 2015ASSIGNED TO PETITION STAFF
Thursday, July 16, 2015TEAS POST PUBLICATION AMENDMENT RECEIVED
Tuesday, June 16, 2015EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Tuesday, December 23, 2014EXTENSION OF TIME TO OPPOSE RECEIVED
Tuesday, December 2, 2014OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 2, 2014PUBLISHED FOR OPPOSITION
Wednesday, November 12, 2014NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 28, 2014LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, October 28, 2014ASSIGNED TO LIE
Thursday, October 9, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, September 17, 2014TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, September 17, 2014CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, September 17, 2014TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, April 2, 2014NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, April 2, 2014NON-FINAL ACTION E-MAILED
Wednesday, April 2, 2014NON-FINAL ACTION WRITTEN
Tuesday, March 11, 2014TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, March 10, 2014CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, March 10, 2014TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, September 16, 2013NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, September 16, 2013NON-FINAL ACTION E-MAILED
Monday, September 16, 2013NON-FINAL ACTION WRITTEN
Tuesday, September 10, 2013ASSIGNED TO EXAMINER
Friday, June 28, 2013NOTICE OF PSEUDO MARK E-MAILED
Thursday, June 27, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, June 21, 2013NEW APPLICATION ENTERED

Related Keywords

smartag system namely chemical polynucleic antibody protein used drug acids applications